These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19500013)

  • 1. HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
    Loo CP; Long BR; Hecht FM; Nixon DF; Michaëlsson J
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):603-5. PubMed ID: 19500013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
    Loubeau M; Ahmad A; Toma E; Menezes J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):137-45. PubMed ID: 9390564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
    Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
    Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.
    Conry SJ; Milkovich KA; Yonkers NL; Rodriguez B; Bernstein HB; Asaad R; Heinzel FP; Tary-Lehmann M; Lederman MM; Anthony DD
    J Virol; 2009 Nov; 83(21):11175-87. PubMed ID: 19692459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
    Long BR; Ndhlovu LC; Oksenberg JR; Lanier LL; Hecht FM; Nixon DF; Barbour JD
    J Virol; 2008 May; 82(10):4785-92. PubMed ID: 18305035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.
    Yonkers NL; Milkovich KA; Rodriguez B; Post AB; Asaad R; Heinzel FP; Valdez H; Tary-Lehmann M; Anthony DD
    Clin Immunol; 2009 May; 131(2):288-97. PubMed ID: 19196551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.
    Rodriguez AR; Hodara V; Murthy K; Morrow L; Sanchez M; Bienvenu AE; Murthy KK
    Cell Immunol; 2014; 288(1-2):24-30. PubMed ID: 24565973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.
    Dillon SM; Lee EJ; Bramante JM; Barker E; Wilson CC
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):259-67. PubMed ID: 24091697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient IL-2 Produced by Activated CD56
    Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
    Front Immunol; 2019; 10():1647. PubMed ID: 31379845
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.
    Goodier MR; Imami N; Moyle G; Gazzard B; Gotch F
    Clin Exp Immunol; 2003 Dec; 134(3):470-6. PubMed ID: 14632753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.
    Thobakgale CF; Fadda L; Lane K; Toth I; Pereyra F; Bazner S; Ndung'u T; Walker BD; Rosenberg ES; Alter G; Carrington M; Allen TM; Altfeld M
    J Virol; 2012 Jun; 86(12):6986-93. PubMed ID: 22496218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential production of IFN-gamma, analyzed at the single-cell level, by specific subsets of human NK and T cells from healthy and HIV(+) subjects.
    Vitale M; Caruso A; Licenziati S; Rodella L; Fiorentini S; Zauli G; Castelli F; Manzoli FA; Turano A
    Cytometry; 2000 Mar; 39(3):189-94. PubMed ID: 10685075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.
    Lisovsky I; Isitman G; Tremblay-McLean A; Song R; DaFonseca S; Lebouchẻ B; Routy JP; Bruneau J; Bernard NF
    Clin Exp Immunol; 2016 Dec; 186(3):336-346. PubMed ID: 27506421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees.
    Rodriguez AR; Arulanandam BP; Hodara VL; McClure HM; Cobb EK; Salas MT; White R; Murthy KK
    J Gen Virol; 2007 Feb; 88(Pt 2):641-651. PubMed ID: 17251583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.
    Zhang T; Li Y; Wang YJ; Wang X; Young M; Douglas SD; Ho WZ
    Antiviral Res; 2007 Feb; 73(2):132-9. PubMed ID: 16997390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
    Huang XL; Fan Z; Murayama T; Rinaldo C
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.
    Azzoni L; Papasavvas E; Chehimi J; Kostman JR; Mounzer K; Ondercin J; Perussia B; Montaner LJ
    J Immunol; 2002 Jun; 168(11):5764-70. PubMed ID: 12023377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.